June 22, 2015 - Curant Health COO, Marc O'Connor, in MedCity News - $1,000 per month for life cholesterol drugs brings immense pressure on prescribers to ensure outstanding medication adherence by patients. The pharmaceutical industry is about to wade into a new battlefield with payers and prescribers. A new class of drugs known as PCSK9 inhibitors restricts a […]
In his latest Managed Healthcare Executive article, Curant Health COO, Marc O’Connor, discusses how to reduce avoidable healthcare costs through the use of innovative medication management with enhanced MTM. There is one certainty in the healthcare industry: there will always be high costs. Fortunately, a large portion of current healthcare spending is avoidable, and all […]
June 22, 2015 - Curant Health COO, Marc O'Connor, in MedCity News - $1,000 per month for life cholesterol drugs brings immense pressure on prescribers to ensure outstanding medication adherence by patients. The pharmaceutical industry is about to wade into a new battlefield with payers and prescribers. A new class of drugs known as PCSK9 inhibitors […]
June 19, 2015 - Curant Health COO, Marc O'Connor, in Specialty Pharmacy Times - There is no question that one of the changes brought about by the ACA is increased scrutiny of healthcare insurance plans by consumers and employers alike. New regulations, economic pressures and patient expectations are changing healthcare in US overall plan quality. […]
It seems that I always leave the Armada Specialty Pharmacy Summit with a handful of takeaway items that stick with me for the remainder of the year. The 2015 conference was no exception. The big learnings I took away from this year’s event all seem to relate to healthcare misalignment and the seismic shift taking […]
May 27, 2015 - Curant Health COO, Marc O'Connor, in Specialty Pharmacy Times - Amidst the health care industry’s seismic shift away from fee-for-service to value-based care, the pharmaceutical industry remains firmly at odds. Manufacturers need to recoup massive R&D costs for curative therapies and PBMs need to drive down costs for their plan sponsors. […]
May 26, 2015 - Curant Health President and CEO, Patrick Dunham, in Fierce Practice Management - When it comes to practice-management headaches, the hassle involved in obtaining prior authorizations from insurers often leads the list of complaints. And while many elements of fee-for-service reimbursement structures will begin to disappear as the industry moves toward value-based […]
We are proud that MTM is becoming the number one topic for many healthcare stakeholders. For instance, the recent 2015 Medication Therapy Management Congress for Health Plans was held in Las Vegas this past month. The main focus on the agenda: increasing the awareness and use of MTM. What’s the golden nugget in all of […]
May 18, 2015 – Atlanta, GA - Curant Health has received a 2015 Georgia Fast 40 award for the third year in a row. The award will be presented by the Atlanta chapter of The Association for Corporate Growth® (ACG), a global professional organization focused on middle-market growth, mergers and acquisitions, and private investment, on […]
May 18, 2015 - Atlanta, GA - Virginia Premier Health Plan (VPHP) has selected Curant Health to participate as a provider of enhanced medication therapy management services for the managed care organization’s more than 185,000 members. An optional, value-add service, Curant’s medication therapy management program includes complete medication assessment and reconciliation, individualized adherence plans, custom […]
